{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T18:38:22Z","timestamp":1784140702881,"version":"3.55.0"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,10,24]],"date-time":"2023-10-24T00:00:00Z","timestamp":1698105600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,10,24]],"date-time":"2023-10-24T00:00:00Z","timestamp":1698105600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100016120","name":"Departamento de Salud, Gobierno de Navarra","doi-asserted-by":"publisher","award":["GNa01\/21"],"award-info":[{"award-number":["GNa01\/21"]}],"id":[{"id":"10.13039\/501100016120","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["FI19\/00302"],"award-info":[{"award-number":["FI19\/00302"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["CD19\/00251"],"award-info":[{"award-number":["CD19\/00251"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015528","name":"Universidad de La Laguna","doi-asserted-by":"crossref","award":["ULL-MS-P14"],"award-info":[{"award-number":["ULL-MS-P14"]}],"id":[{"id":"10.13039\/100015528","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100007680","name":"Universidad P\u00fablica de Navarra","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100007680","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Biol Sex Differ"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Aortic stenosis (AS) is characterized by inflammation, fibrosis, osteogenesis and angiogenesis. Men and women develop these mechanisms differently. Galectin-3 (Gal-3) is a pro-inflammatory and pro-osteogenic lectin in AS. In this work, we aim to analyse a potential sex-differential role of Gal-3 in AS.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>226 patients (61.50% men) with severe AS undergoing surgical aortic valve (AV) replacement were recruited. In AVs, Gal-3 expression and its relationship with inflammatory, osteogenic and angiogenic markers was assessed. Valve interstitial cells (VICs) were primary cultured to perform in vitro experiments.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Proteomic analysis revealed that intracellular Gal-3 was over-expressed in VICs of male AS patients. Gal-3 secretion was also higher in men\u2019s VICs as compared to women\u2019s. In human AVs, Gal-3 protein levels were significantly higher in men, with stronger immunostaining in VICs with myofibroblastic phenotype and valve endothelial cells. Gal-3 levels in AVs were positively correlated with inflammatory markers in both sexes. Gal-3 expression was also positively correlated with osteogenic markers mainly in men AVs, and with angiogenic molecules only in this sex. In vitro<jats:italic>,<\/jats:italic>Gal-3 treatment induced expression of inflammatory, osteogenic and angiogenic markers in male\u2019s VICs, while it only upregulated inflammatory and osteogenic molecules in women-derived cells. Gal-3 blockade with pharmacological inhibitors (modified citrus pectin and G3P-01) prevented the upregulation of inflammatory, osteogenic and angiogenic molecules.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Gal-3 plays a sex-differential role in the setting of AS, and it could be a new sex-specific therapeutic target controlling pathological features of AS in VICs.<\/jats:p><\/jats:sec><jats:sec><jats:title>Graphical Abstract<\/jats:title><\/jats:sec>","DOI":"10.1186\/s13293-023-00556-1","type":"journal-article","created":{"date-parts":[[2023,10,24]],"date-time":"2023-10-24T13:03:24Z","timestamp":1698152604000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Sex-specific role of galectin-3 in aortic stenosis"],"prefix":"10.1186","volume":"14","author":[{"given":"Lara","family":"Matilla","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ernesto","family":"Mart\u00edn-N\u00fa\u00f1ez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mattie","family":"Garaikoetxea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adela","family":"Navarro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ibai","family":"Tamayo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amaya","family":"Fern\u00e1ndez-Celis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alicia","family":"Gainza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joaqu\u00edn","family":"Fern\u00e1ndez-Irigoyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enrique","family":"Santamar\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pieter","family":"Muntendam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Virginia","family":"\u00c1lvarez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafael","family":"S\u00e1daba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Jover","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3728-2606","authenticated-orcid":false,"given":"Natalia","family":"L\u00f3pez-Andr\u00e9s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,10,24]]},"reference":[{"issue":"21","key":"556_CR1","doi-asserted-by":"publisher","first-page":"1696","DOI":"10.1136\/heartjnl-2016-310894","volume":"103","author":"P Andell","year":"2017","unstructured":"Andell P, Li X, Martinsson A, Andersson C, Stagmo M, Zoller B, et al. Epidemiology of valvular heart disease in a Swedish nationwide hospital-based register study. Heart. 2017;103(21):1696\u2013703.","journal-title":"Heart"},{"issue":"4","key":"556_CR2","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1161\/ATVBAHA.119.313067","volume":"40","author":"PR Goody","year":"2020","unstructured":"Goody PR, Hosen MR, Christmann D, Niepmann ST, Zietzer A, Adam M, et al. Aortic valve stenosis: from basic mechanisms to novel therapeutic targets. Arterioscler Thromb Vasc Biol. 2020;40(4):885\u2013900.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"7","key":"556_CR3","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1093\/eurheartj\/ehab395","volume":"43","author":"A Vahanian","year":"2022","unstructured":"Vahanian A, Beyersdorf F, Praz F, Milojevic M, Baldus S, Bauersachs J, et al. 2021 ESC\/EACTS guidelines for the management of valvular heart disease. Eur Heart J. 2022;43(7):561\u2013632.","journal-title":"Eur Heart J"},{"issue":"1","key":"556_CR4","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1161\/ATVBAHA.120.314287","volume":"41","author":"N Gendron","year":"2021","unstructured":"Gendron N, Rosa M, Blandinieres A, Sottejeau Y, Rossi E, Van Belle E, et al. Human aortic valve interstitial cells display proangiogenic properties during calcific aortic valve disease. Arterioscler Thromb Vasc Biol. 2021;41(1):415\u201329.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"556_CR5","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.ijcard.2021.07.032","volume":"339","author":"C Maffeis","year":"2021","unstructured":"Maffeis C, Rossi A, Faggiano P. Aortic valve stenosis burden: where we are now? Int J Cardiol. 2021;339:128\u20139.","journal-title":"Int J Cardiol"},{"issue":"27","key":"556_CR6","doi-asserted-by":"publisher","first-page":"2683","DOI":"10.1093\/eurheartj\/ehab242","volume":"42","author":"D Bienjonetti-Boudreau","year":"2021","unstructured":"Bienjonetti-Boudreau D, Fleury MA, Voisine M, Paquin A, Chouinard I, Tailleur M, et al. Impact of sex on the management and outcome of aortic stenosis patients. Eur Heart J. 2021;42(27):2683\u201391.","journal-title":"Eur Heart J"},{"issue":"4","key":"556_CR7","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1161\/CIRCRESAHA.121.319914","volume":"130","author":"JT DesJardin","year":"2022","unstructured":"DesJardin JT, Chikwe J, Hahn RT, Hung JW, Delling FN. Sex differences and similarities in valvular heart disease. Circ Res. 2022;130(4):455\u201373.","journal-title":"Circ Res"},{"key":"556_CR8","doi-asserted-by":"publisher","first-page":"818371","DOI":"10.3389\/fcvm.2022.818371","volume":"9","author":"L Matilla","year":"2022","unstructured":"Matilla L, Garaikoetxea M, Arrieta V, Garcia-Pena A, Fernandez-Celis A, Navarro A, et al. Sex-differences in aortic stenosis: mechanistic insights and clinical implications. Front Cardiovasc Med. 2022;9:818371.","journal-title":"Front Cardiovasc Med"},{"issue":"4","key":"556_CR9","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1161\/CIRCRESAHA.116.309306","volume":"120","author":"L Simard","year":"2017","unstructured":"Simard L, Cote N, Dagenais F, Mathieu P, Couture C, Trahan S, et al. Sex-related discordance between aortic valve calcification and hemodynamic severity of aortic stenosis: is valvular fibrosis the explanation? Circ Res. 2017;120(4):681\u201391.","journal-title":"Circ Res"},{"key":"556_CR10","doi-asserted-by":"publisher","first-page":"971802","DOI":"10.3389\/fcvm.2022.971802","volume":"9","author":"L Matilla","year":"2022","unstructured":"Matilla L, Martin-Nunez E, Garaikoetxea M, Navarro A, Vico JA, Arrieta V, et al. Characterization of the sex-specific pattern of angiogenesis and lymphangiogenesis in aortic stenosis. Front Cardiovasc Med. 2022;9:971802.","journal-title":"Front Cardiovasc Med"},{"issue":"1","key":"556_CR11","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1161\/ATVBAHA.112.300569","volume":"33","author":"L Calvier","year":"2013","unstructured":"Calvier L, Miana M, Reboul P, Cachofeiro V, Martinez-Martinez E, de Boer RA, et al. Galectin-3 mediates aldosterone-induced vascular fibrosis. Arterioscler Thromb Vasc Biol. 2013;33(1):67\u201375.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"11","key":"556_CR12","doi-asserted-by":"publisher","first-page":"e111836","DOI":"10.1371\/journal.pone.0111836","volume":"9","author":"H Halimi","year":"2014","unstructured":"Halimi H, Rigato A, Byrne D, Ferracci G, Sebban-Kreuzer C, ElAntak L, et al. Glycan dependence of Galectin-3 self-association properties. PLoS ONE. 2014;9(11):e111836.","journal-title":"PLoS ONE"},{"issue":"11","key":"556_CR13","doi-asserted-by":"publisher","first-page":"2481","DOI":"10.3390\/ijms18112481","volume":"18","author":"C Iacobini","year":"2017","unstructured":"Iacobini C, Fantauzzi CB, Pugliese G, Menini S. Role of Galectin-3 in bone cell differentiation, bone pathophysiology and vascular osteogenesis. Int J Mol Sci. 2017;18(11):2481.","journal-title":"Int J Mol Sci"},{"issue":"3","key":"556_CR14","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1161\/HYPERTENSIONAHA.118.11874","volume":"73","author":"E Martinez-Martinez","year":"2019","unstructured":"Martinez-Martinez E, Brugnolaro C, Ibarrola J, Ravassa S, Buonafine M, Lopez B, et al. CT-1 (Cardiotrophin-1)-Gal-3 (Galectin-3) axis in cardiac fibrosis and inflammation. Hypertension. 2019;73(3):602\u201311.","journal-title":"Hypertension"},{"issue":"11","key":"556_CR15","doi-asserted-by":"publisher","first-page":"e004360","DOI":"10.1161\/JAHA.116.004360","volume":"5","author":"JR Sadaba","year":"2016","unstructured":"Sadaba JR, Martinez-Martinez E, Arrieta V, Alvarez V, Fernandez-Celis A, Ibarrola J, et al. Role for Galectin-3 in calcific aortic valve stenosis. J Am Heart Assoc. 2016;5(11):e004360.","journal-title":"J Am Heart Assoc"},{"issue":"2","key":"556_CR16","doi-asserted-by":"publisher","first-page":"196","DOI":"10.21037\/cdt-21-506","volume":"12","author":"J Luo","year":"2022","unstructured":"Luo J, Wang S, Liu X, Zheng Q, Wang Z, Huang Y, et al. Galectin-3 promotes calcification of human aortic valve interstitial cells via the NF-kappa B signaling pathway. Cardiovasc Diagn Ther. 2022;12(2):196\u2013207.","journal-title":"Cardiovasc Diagn Ther"},{"issue":"14","key":"556_CR17","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1016\/j.jacc.2012.04.053","volume":"60","author":"JE Ho","year":"2012","unstructured":"Ho JE, Liu C, Lyass A, Courchesne P, Pencina MJ, Vasan RS, et al. Galectin-3, a marker of cardiac fibrosis, predicts incident heart failure in the community. J Am Coll Cardiol. 2012;60(14):1249\u201356.","journal-title":"J Am Coll Cardiol"},{"issue":"6","key":"556_CR18","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1038\/sj.ijo.0802006","volume":"26","author":"AS Jackson","year":"2002","unstructured":"Jackson AS, Stanforth PR, Gagnon J, Rankinen T, Leon AS, Rao DC, et al. The effect of sex, age and race on estimating percentage body fat from body mass index: the heritage family study. Int J Obes Relat Metab Disord. 2002;26(6):789\u201396.","journal-title":"Int J Obes Relat Metab Disord"},{"issue":"2","key":"556_CR19","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1095\/biolreprod.112.099234","volume":"87","author":"H Yang","year":"2012","unstructured":"Yang H, Lei C, Cheng C, Feng Y, Zhang W, Petracco RG, et al. The antiapoptotic effect of galectin-3 in human endometrial cells under the regulation of estrogen and progesterone. Biol Reprod. 2012;87(2):39.","journal-title":"Biol Reprod"},{"issue":"11","key":"556_CR20","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1177\/1933719111407212","volume":"18","author":"H Yang","year":"2011","unstructured":"Yang H, Taylor HS, Lei C, Cheng C, Zhang W. Hormonal regulation of galectin 3 in trophoblasts and its effects on endometrium. Reprod Sci. 2011;18(11):1118\u201327.","journal-title":"Reprod Sci"},{"issue":"32","key":"556_CR21","doi-asserted-by":"publisher","first-page":"2538","DOI":"10.1093\/eurheartj\/eht152","volume":"34","author":"S Meyer","year":"2013","unstructured":"Meyer S, van der Meer P, van Deursen VM, Jaarsma T, van Veldhuisen DJ, van der Wal MH, et al. Neurohormonal and clinical sex differences in heart failure. Eur Heart J. 2013;34(32):2538\u201347.","journal-title":"Eur Heart J"},{"issue":"2","key":"556_CR22","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1373\/clinchem.2015.246553","volume":"62","author":"EI Schindler","year":"2016","unstructured":"Schindler EI, Szymanski JJ, Hock KG, Geltman EM, Scott MG. Short- and long-term biologic variability of Galectin-3 and other cardiac biomarkers in patients with stable heart failure and healthy adults. Clin Chem. 2016;62(2):360\u20136.","journal-title":"Clin Chem"},{"issue":"2","key":"556_CR23","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1093\/eurheartj\/ehy394","volume":"40","author":"FJ Neumann","year":"2019","unstructured":"Neumann FJ, Sousa-Uva M, Ahlsson A, Alfonso F, Banning AP, Benedetto U, et al. 2018 ESC\/EACTS guidelines on myocardial revascularization. Eur Heart J. 2019;40(2):87\u2013165.","journal-title":"Eur Heart J"},{"issue":"6","key":"556_CR24","doi-asserted-by":"publisher","first-page":"e0127844","DOI":"10.1371\/journal.pone.0127844","volume":"10","author":"N Latif","year":"2015","unstructured":"Latif N, Quillon A, Sarathchandra P, McCormack A, Lozanoski A, Yacoub MH, et al. Modulation of human valve interstitial cell phenotype and function using a fibroblast growth factor 2 formulation. PLoS ONE. 2015;10(6):e0127844.","journal-title":"PLoS ONE"},{"issue":"1","key":"556_CR25","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1038\/s41467-017-00249-5","volume":"8","author":"BC Collins","year":"2017","unstructured":"Collins BC, Hunter CL, Liu Y, Schilling B, Rosenberger G, Bader SL, et al. Multi-laboratory assessment of reproducibility, qualitative and quantitative performance of SWATH-mass spectrometry. Nat Commun. 2017;8(1):291.","journal-title":"Nat Commun"},{"issue":"6","key":"556_CR26","doi-asserted-by":"publisher","first-page":"e12996","DOI":"10.1111\/bpa.12996","volume":"31","author":"I Ferrer","year":"2021","unstructured":"Ferrer I, Andres-Benito P, Ausin K, Pamplona R, Del Rio JA, Fernandez-Irigoyen J, et al. Dysregulated protein phosphorylation: a determining condition in the continuum of brain aging and Alzheimer\u2019s disease. Brain Pathol. 2021;31(6):e12996.","journal-title":"Brain Pathol"},{"issue":"9","key":"556_CR27","doi-asserted-by":"publisher","first-page":"1638","DOI":"10.1074\/mcp.T600050-MCP200","volume":"6","author":"IV Shilov","year":"2007","unstructured":"Shilov IV, Seymour SL, Patel AA, Loboda A, Tang WH, Keating SP, et al. The Paragon Algorithm, a next generation search engine that uses sequence temperature values and feature probabilities to identify peptides from tandem mass spectra. Mol Cell Proteomics. 2007;6(9):1638\u201355.","journal-title":"Mol Cell Proteomics"},{"issue":"9","key":"556_CR28","doi-asserted-by":"publisher","first-page":"3661","DOI":"10.1021\/pr070492f","volume":"7","author":"WH Tang","year":"2008","unstructured":"Tang WH, Shilov IV, Seymour SL. Nonlinear fitting method for determining local false discovery rates from decoy database searches. J Proteome Res. 2008;7(9):3661\u20137.","journal-title":"J Proteome Res"},{"issue":"6","key":"556_CR29","doi-asserted-by":"publisher","first-page":"O111016717","DOI":"10.1074\/mcp.O111.016717","volume":"11","author":"LC Gillet","year":"2012","unstructured":"Gillet LC, Navarro P, Tate S, Rost H, Selevsek N, Reiter L, et al. Targeted data extraction of the MS\/MS spectra generated by data-independent acquisition: a new concept for consistent and accurate proteome analysis. Mol Cell Proteomics. 2012;11(6):O111016717.","journal-title":"Mol Cell Proteomics"},{"issue":"9","key":"556_CR30","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1038\/nmeth.3901","volume":"13","author":"S Tyanova","year":"2016","unstructured":"Tyanova S, Temu T, Sinitcyn P, Carlson A, Hein MY, Geiger T, et al. The Perseus computational platform for comprehensive analysis of (prote)omics data. Nat Methods. 2016;13(9):731\u201340.","journal-title":"Nat Methods"},{"issue":"6","key":"556_CR31","doi-asserted-by":"publisher","first-page":"639","DOI":"10.3390\/biomedicines9060639","volume":"9","author":"E Jover","year":"2021","unstructured":"Jover E, Matilla L, Garaikoetxea M, Fernandez-Celis A, Muntendam P, Jaisser F, et al. Beneficial effects of mineralocorticoid receptor pathway blockade against endothelial inflammation induced by SARS-CoV-2 spike protein. Biomedicines. 2021;9(6):639.","journal-title":"Biomedicines"},{"issue":"16","key":"556_CR32","doi-asserted-by":"publisher","first-page":"5620","DOI":"10.3390\/ijms21165620","volume":"21","author":"VI Summerhill","year":"2020","unstructured":"Summerhill VI, Moschetta D, Orekhov AN, Poggio P, Myasoedova VA. Sex-specific features of calcific aortic valve disease. Int J Mol Sci. 2020;21(16):5620.","journal-title":"Int J Mol Sci"},{"issue":"10","key":"556_CR33","doi-asserted-by":"publisher","first-page":"e015610","DOI":"10.1161\/JAHA.119.015610","volume":"9","author":"M Voisine","year":"2020","unstructured":"Voisine M, Hervault M, Shen M, Boilard AJ, Filion B, Rosa M, et al. Age, sex, and valve phenotype differences in fibro-calcific remodeling of calcified aortic valve. J Am Heart Assoc. 2020;9(10):e015610.","journal-title":"J Am Heart Assoc"},{"issue":"7","key":"556_CR34","doi-asserted-by":"publisher","first-page":"e39980","DOI":"10.1371\/journal.pone.0039980","volume":"7","author":"CM McCoy","year":"2012","unstructured":"McCoy CM, Nicholas DQ, Masters KS. Sex-related differences in gene expression by porcine aortic valvular interstitial cells. PLoS ONE. 2012;7(7):e39980.","journal-title":"PLoS ONE"},{"key":"556_CR35","doi-asserted-by":"publisher","first-page":"736303","DOI":"10.3389\/fcvm.2021.736303","volume":"8","author":"V Nelson","year":"2021","unstructured":"Nelson V, Patil V, Simon LR, Schmidt K, McCoy CM, Masters KS. Angiogenic secretion profile of valvular interstitial cells varies with cellular sex and phenotype. Front Cardiovasc Med. 2021;8:736303.","journal-title":"Front Cardiovasc Med"},{"issue":"1","key":"556_CR36","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.jchf.2014.08.002","volume":"3","author":"L Calvier","year":"2015","unstructured":"Calvier L, Martinez-Martinez E, Miana M, Cachofeiro V, Rousseau E, Sadaba JR, et al. The impact of galectin-3 inhibition on aldosterone-induced cardiac and renal injuries. JACC Heart Fail. 2015;3(1):59\u201367.","journal-title":"JACC Heart Fail"},{"issue":"5","key":"556_CR37","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/j.jash.2017.03.008","volume":"11","author":"J He","year":"2017","unstructured":"He J, Li X, Luo H, Li T, Zhao L, Qi Q, et al. Galectin-3 mediates the pulmonary arterial hypertension-induced right ventricular remodeling through interacting with NADPH oxidase 4. J Am Soc Hypertens. 2017;11(5):275\u201389.","journal-title":"J Am Soc Hypertens"},{"issue":"1","key":"556_CR38","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1093\/eurjhf\/hfr151","volume":"14","author":"N Lopez-Andres","year":"2012","unstructured":"Lopez-Andres N, Rossignol P, Iraqi W, Fay R, Nuee J, Ghio S, et al. Association of galectin-3 and fibrosis markers with long-term cardiovascular outcomes in patients with heart failure, left ventricular dysfunction, and dyssynchrony: insights from the CARE-HF (Cardiac Resynchronization in Heart Failure) trial. Eur J Heart Fail. 2012;14(1):74\u201381.","journal-title":"Eur J Heart Fail"},{"issue":"3","key":"556_CR39","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1093\/cvr\/cvt206","volume":"100","author":"S Menini","year":"2013","unstructured":"Menini S, Iacobini C, Ricci C, Blasetti Fantauzzi C, Salvi L, Pesce CM, et al. The galectin-3\/RAGE dyad modulates vascular osteogenesis in atherosclerosis. Cardiovasc Res. 2013;100(3):472\u201380.","journal-title":"Cardiovasc Res"},{"issue":"19","key":"556_CR40","doi-asserted-by":"publisher","first-page":"3121","DOI":"10.1161\/01.CIR.0000147181.65298.4D","volume":"110","author":"UC Sharma","year":"2004","unstructured":"Sharma UC, Pokharel S, van Brakel TJ, van Berlo JH, Cleutjens JP, Schroen B, et al. Galectin-3 marks activated macrophages in failure-prone hypertrophied hearts and contributes to cardiac dysfunction. Circulation. 2004;110(19):3121\u20138.","journal-title":"Circulation"},{"issue":"9","key":"556_CR41","doi-asserted-by":"publisher","first-page":"e006339","DOI":"10.1161\/JAHA.117.006339","volume":"6","author":"A Rutkovskiy","year":"2017","unstructured":"Rutkovskiy A, Malashicheva A, Sullivan G, Bogdanova M, Kostareva A, Stenslokken KO, et al. Valve interstitial cells: the key to understanding the pathophysiology of heart valve calcification. J Am Heart Assoc. 2017;6(9):e006339.","journal-title":"J Am Heart Assoc"},{"issue":"6","key":"556_CR42","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1007\/s12265-011-9312-0","volume":"4","author":"J Bischoff","year":"2011","unstructured":"Bischoff J, Aikawa E. Progenitor cells confer plasticity to cardiac valve endothelium. J Cardiovasc Transl Res. 2011;4(6):710\u20139.","journal-title":"J Cardiovasc Transl Res"},{"issue":"1","key":"556_CR43","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1136\/heart.85.1.13","volume":"85","author":"A Farzaneh-Far","year":"2001","unstructured":"Farzaneh-Far A, Proudfoot D, Shanahan C, Weissberg PL. Vascular and valvar calcification: recent advances. Heart. 2001;85(1):13\u20137.","journal-title":"Heart"},{"issue":"4","key":"556_CR44","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1038\/s41419-021-03603-0","volume":"12","author":"W Jia","year":"2021","unstructured":"Jia W, Wang Z, Gao C, Wu J, Wu Q. Trajectory modeling of endothelial-to-mesenchymal transition reveals galectin-3 as a mediator in pulmonary fibrosis. Cell Death Dis. 2021;12(4):327.","journal-title":"Cell Death Dis"},{"issue":"4","key":"556_CR45","doi-asserted-by":"publisher","first-page":"731","DOI":"10.14336\/AD.2018.1001","volume":"10","author":"T Li","year":"2019","unstructured":"Li T, Zha L, Luo H, Li S, Zhao L, He J, et al. Galectin-3 mediates endothelial-to-mesenchymal transition in pulmonary arterial hypertension. Aging Dis. 2019;10(4):731\u201345.","journal-title":"Aging Dis"},{"issue":"2","key":"556_CR46","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1159\/000495331","volume":"51","author":"L Zhang","year":"2018","unstructured":"Zhang L, Li YM, Zeng XX, Wang XY, Chen SK, Gui LX, et al. Galectin-3- mediated transdifferentiation of pulmonary artery endothelial cells contributes to hypoxic pulmonary vascular remodeling. Cell Physiol Biochem. 2018;51(2):763\u201377.","journal-title":"Cell Physiol Biochem"},{"issue":"2","key":"556_CR47","doi-asserted-by":"publisher","first-page":"199","DOI":"10.23938\/ASSN.0643","volume":"42","author":"V Arrieta","year":"2019","unstructured":"Arrieta V, Sadaba JR, Alvarez V, Rodriguez JA, Lopez-Andres N. Galectin-3 as a novel biotarget in cardiovascular alterations associated to development of severe aortic stenosis. An Sist Sanit Navar. 2019;42(2):199\u2013208.","journal-title":"An Sist Sanit Navar"},{"issue":"5","key":"556_CR48","doi-asserted-by":"publisher","first-page":"H1068","DOI":"10.1152\/ajpheart.00690.2019","volume":"318","author":"Z Sun","year":"2020","unstructured":"Sun Z, Li L, Zhang L, Yan J, Shao C, Bao Z, et al. Macrophage galectin-3 enhances intimal translocation of vascular calcification in diabetes mellitus. Am J Physiol Heart Circ Physiol. 2020;318(5):H1068\u201379.","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"4","key":"556_CR49","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1007\/s00592-018-1273-1","volume":"56","author":"Z Sun","year":"2019","unstructured":"Sun Z, Wang Z, Li L, Yan J, Shao C, Bao Z, et al. RAGE\/galectin-3 yields intraplaque calcification transformation via sortilin. Acta Diabetol. 2019;56(4):457\u201372.","journal-title":"Acta Diabetol"},{"key":"556_CR50","doi-asserted-by":"publisher","first-page":"734346","DOI":"10.3389\/fcell.2021.734346","volume":"9","author":"I Cano","year":"2021","unstructured":"Cano I, Hu Z, AbuSamra DB, Saint-Geniez M, Ng YSE, Argueso P, et al. Galectin-3 enhances vascular endothelial growth factor-a receptor 2 activity in the presence of vascular endothelial growth factor. Front Cell Dev Biol. 2021;9:734346.","journal-title":"Front Cell Dev Biol"},{"issue":"2","key":"556_CR51","doi-asserted-by":"publisher","first-page":"e89025","DOI":"10.1371\/journal.pone.0089025","volume":"9","author":"J Liao","year":"2014","unstructured":"Liao J, Hu N, Zhou N, Lin L, Zhao C, Yi S, et al. Sox9 potentiates BMP2-induced chondrogenic differentiation and inhibits BMP2-induced osteogenic differentiation. PLoS ONE. 2014;9(2):e89025.","journal-title":"PLoS ONE"},{"issue":"7","key":"556_CR52","first-page":"75","volume":"8","author":"RB Hinton","year":"2021","unstructured":"Hinton RB, Juraszek AL, Opoka AM, Landis BJ, Smith JM, Mecham RP, et al. Early aberrant angiogenesis due to elastic fiber fragmentation in aortic valve disease. J Cardiovasc Dev Dis. 2021;8(7):75.","journal-title":"J Cardiovasc Dev Dis"},{"issue":"3","key":"556_CR53","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1186\/ar292","volume":"3","author":"DA Walsh","year":"2001","unstructured":"Walsh DA, Pearson CI. Angiogenesis in the pathogenesis of inflammatory joint and lung diseases. Arthritis Res. 2001;3(3):147\u201353.","journal-title":"Arthritis Res"},{"issue":"5","key":"556_CR54","doi-asserted-by":"publisher","first-page":"1667","DOI":"10.1210\/endo.141.5.7458","volume":"141","author":"MM Deckers","year":"2000","unstructured":"Deckers MM, Karperien M, van der Bent C, Yamashita T, Papapoulos SE, Lowik CW. Expression of vascular endothelial growth factors and their receptors during osteoblast differentiation. Endocrinology. 2000;141(5):1667\u201374.","journal-title":"Endocrinology"},{"issue":"9","key":"556_CR55","doi-asserted-by":"publisher","first-page":"1981","DOI":"10.1084\/jem.20090121","volume":"207","author":"AI Markowska","year":"2010","unstructured":"Markowska AI, Liu FT, Panjwani N. Galectin-3 is an important mediator of VEGF- and bFGF-mediated angiogenic response. J Exp Med. 2010;207(9):1981\u201393.","journal-title":"J Exp Med"},{"key":"556_CR56","doi-asserted-by":"publisher","first-page":"5284728","DOI":"10.1155\/2020\/5284728","volume":"2020","author":"Z Gao","year":"2020","unstructured":"Gao Z, Liu Z, Wang R, Zheng Y, Li H, Yang L. Galectin-3 is a potential mediator for atherosclerosis. J Immunol Res. 2020;2020:5284728.","journal-title":"J Immunol Res"}],"container-title":["Biology of Sex Differences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13293-023-00556-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13293-023-00556-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13293-023-00556-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,31]],"date-time":"2024-10-31T18:39:47Z","timestamp":1730399987000},"score":1,"resource":{"primary":{"URL":"https:\/\/bsd.biomedcentral.com\/articles\/10.1186\/s13293-023-00556-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,24]]},"references-count":56,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["556"],"URL":"https:\/\/doi.org\/10.1186\/s13293-023-00556-1","relation":{},"ISSN":["2042-6410"],"issn-type":[{"value":"2042-6410","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10,24]]},"assertion":[{"value":"20 July 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 October 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 October 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study protocol was approved by The Institutional Human Research Committee (Comit\u00e9 \u00c9tico de Experimentaci\u00f3n Cl\u00ednica. Gobierno de Navarra, Departamento de Salud) approved the study protocols (Ethics numbers 17\/2013 and PI2019\/59) that were performed in accordance to the ethical guidelines of the 1975 Declaration of Helsinki. Written informed consent was obtained from all patients involved in the stud.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"NLA and PM report shareholder interest in G3-Pharmaceuticals. PM reports having received remuneration from G3-Pharmaceuticals.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"72"}}